期刊文献+

细支气管肺癌的内科治疗进展

下载PDF
导出
摘要 细支气管肺癌(BAC)是非小细胞肺癌(NSCLC)的一个亚型,具有独特的流行病学、病理学、影像学特征及临床特点。目前仅有的资料显示,对化疗更为敏感还是更为耐药尚无定论,对EGFR-TKI有着独特的敏感性,本文综述近年来BAC在化疗和靶向治疗方面的进展。
出处 《现代医药卫生》 2010年第16期2476-2477,共2页 Journal of Modern Medicine & Health
  • 相关文献

参考文献16

  • 1Brambilla E ,Travis WD ,Collby TV ,et al.The new World Health Organization classification of lung tumors[J].Eur Respir J, 2007,9 ( 18 ) : 1059.
  • 2Beasley MB,Bramhilla E,Travis WD.The 2004 World Health Organization classification of lung tumors[J].Semin in Roontgenol, 2007, 40(2) : 90.
  • 3吴一龙,蒋国樑,陆舜,周清华,张力,无.支气管肺泡细胞癌之中国共识[J].循证医学,2006,6(4):227-230. 被引量:28
  • 4Ebright MI,Zakowski MF,Martin J,et al.Clinical Pattern and Pathologic stage but not histologic features predict outcone for bronchioloalveolar carcinoma[J]. Ann-Thorac-Surg,2007,74(5): 1640.
  • 5Goodwin Lo,Mason JM, Hajdu SI.Gene expression patterns of paired bronchioloalveolar carcinoma and benign lung tissue[J].Ann-Clin-Lab-Sci, 2008,31 (4) : 369.
  • 6Schiller JH, Harrington D, Belani CP,et ahComparison of four chemotherapy regimens for advanced non-small-cell lung cancer[J]. Nengl J Med ,2008,34(6) :92.
  • 7West HL,Crowley JJ,Vance RB, et al.Advanced bronchioloalveolar carcinoma:A phase Ⅱ trial of paclitaxel by 96-hour infusion (SWOG9714).A Southwest Oncnlogy GroupSTUDY[J].Ann Oncol, 2005,16(7) : 1076.
  • 8Scagliotti GV,Smit E, Bosquee L,et al.A phase Ⅱ study of pachtaxel in advanced ronchioloalveolar carcinoma (EORTC trial 08956)[J]. Lung Cancer, 2006,50(1) : 91.
  • 9赵兰,褚海青,李惠萍,何国钧.吉西他滨、顺铂联合治疗晚期细支气管肺泡癌[J].中国肺癌杂志,2002,5(6):467-468. 被引量:8
  • 10Lrist MG, Sandler A, Miller V, et al.Cigarette smoking history predicts sensitivitu to erlotinib: Result of a phase Ⅱ trial in patients with bronchioloalveolar carcinoma(BAC)[J].Proc Am Soc Clin Oncol ,2005,23(13) :631s.

二级参考文献16

  • 1Brambilla E, Travis WD, Colby TV, et al. The new World Health Organization classification of lung tumours[J]. Eur Respir J, 2001,18:1059-1068.
  • 2Beasley MB, Brambilla E, Travis WD. The 2004 World Health Organization classification of lung tumors [J]. Semin in Roentgenol, 2005,40(2) : 90-97.
  • 3Kris MG, Sandler A, Miller V, et al. Cigarette smoking history predicts sensitivity to erlotinib: Results of a phase Ⅱ trial in patients with bronchioloalveolar cacinoma (BAC) [J].Proc Am Soc Clin Oncol, 2004,23:631S.
  • 4Jackman DM, Chirieac LR, Janne PA. Bronchioloalveolar carcinoma: A review of the epidemiology, pathology, and treatment [J]. Semin Respir Crit Care Med, 2005,26 (3):342-352.
  • 5Ebright MI, Zakowski MF, Martin J, et al. Clinical pattern and pathologic stage but not histologic features predict outcome for bronchioloalveolar carcinoma [J ]. Ann Thorac Surg, 2002,74(5) : 1640-1646.
  • 6Furak J, Trojan I, Szoke T, et al. Bronchioloalveolar lung cancer: occurrence, surgical treatment and survival [J]. Eur Cardiothorac Surg, 2003,23 : 818-823.
  • 7Roberts PF, Straznicka M, Lara PN, et al. Resection of multifocal non-small cell lung cancer when the bronchioloalveolar subtype is involved [J]. J Thorac Cardiovasc Surg, 2003,126: 1597-1601.
  • 8West HL, Crowley J J, Vance RB, et al. Advanced brocnhioloalveolar carcinoma: A phase Ⅱ trial of paclitaxel by 96-hour infusion (SWOG 9714) [J]. Ann Oncol : in press.
  • 9West H, Franklin WA, McCoy J, et al. Gefitinib therapy in advanced bronchioloalveolar carcinoma: Southwest Oncology Group Study S0126 [J]. J Clin Oncol, 2006,24(12):1807-1813.
  • 10Lee DH, Han JY, Lee HG, et al. Gefitinib as a first-line therapy of advanced or metastatic adenocarcinoma of the lung in never-smokers [J]. Clin Cancer Res, 2005,11 (8) :3032-3037.

共引文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部